paclitaxel (oral formulation)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for paclitaxel (oral formulation), covering 2024-09-19 to 2025-08-26. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer [NA]